These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 16785503)

  • 1. Injury-induced suppression of effector T cell immunity requires CD1d-positive APCs and CD1d-restricted NKT cells.
    Palmer JL; Tulley JM; Kovacs EJ; Gamelli RL; Taniguchi M; Faunce DE
    J Immunol; 2006 Jul; 177(1):92-9. PubMed ID: 16785503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A role for CD1d-restricted NKT cells in injury-associated T cell suppression.
    Faunce DE; Gamelli RL; Choudhry MA; Kovacs EJ
    J Leukoc Biol; 2003 Jun; 73(6):747-55. PubMed ID: 12773507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A subset of NKT cells that lacks the NK1.1 marker, expresses CD1d molecules, and autopresents the alpha-galactosylceramide antigen.
    Hameg A; Apostolou I; Leite-De-Moraes M; Gombert JM; Garcia C; Koezuka Y; Bach JF; Herbelin A
    J Immunol; 2000 Nov; 165(9):4917-26. PubMed ID: 11046017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NKT cell-derived RANTES recruits APCs and CD8+ T cells to the spleen during the generation of regulatory T cells in tolerance.
    Faunce DE; Stein-Streilein J
    J Immunol; 2002 Jul; 169(1):31-8. PubMed ID: 12077225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Control of NKT cell differentiation by tissue-specific microenvironments.
    Yang Y; Ueno A; Bao M; Wang Z; Im JS; Porcelli S; Yoon JW
    J Immunol; 2003 Dec; 171(11):5913-20. PubMed ID: 14634102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of injury-induced suppression of T-cell immunity by the CD1d/NKT cell-specific ligand alpha-galactosylceramide.
    Tulley JM; Palmer JL; Gamelli RL; Faunce DE
    Shock; 2008 Feb; 29(2):269-77. PubMed ID: 17693934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct regulatory role of NKT cells in allogeneic graft survival is dependent on the quantitative strength of antigenicity.
    Oh K; Kim S; Park SH; Gu H; Roopenian D; Chung DH; Kim YS; Lee DS
    J Immunol; 2005 Feb; 174(4):2030-6. PubMed ID: 15699132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD1d-restricted NKT cells contribute to the age-associated decline of T cell immunity.
    Faunce DE; Palmer JL; Paskowicz KK; Witte PL; Kovacs EJ
    J Immunol; 2005 Sep; 175(5):3102-9. PubMed ID: 16116199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Up-regulation of CD1d expression restores the immunoregulatory function of NKT cells and prevents autoimmune diabetes in nonobese diabetic mice.
    Falcone M; Facciotti F; Ghidoli N; Monti P; Olivieri S; Zaccagnino L; Bonifacio E; Casorati G; Sanvito F; Sarvetnick N
    J Immunol; 2004 May; 172(10):5908-16. PubMed ID: 15128771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A cell-type specific CD1d expression program modulates invariant NKT cell development and function.
    Zimmer MI; Colmone A; Felio K; Xu H; Ma A; Wang CR
    J Immunol; 2006 Feb; 176(3):1421-30. PubMed ID: 16424169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of CD1d under the control of a MHC class Ia promoter skews the development of NKT cells, but not CD8+ T cells.
    Xu H; Chun T; Colmone A; Nguyen H; Wang CR
    J Immunol; 2003 Oct; 171(8):4105-12. PubMed ID: 14530332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD1d on antigen-transporting APC and splenic marginal zone B cells promotes NKT cell-dependent tolerance.
    Sonoda KH; Stein-Streilein J
    Eur J Immunol; 2002 Mar; 32(3):848-57. PubMed ID: 11870629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycosylphosphatidylinositol-anchored mucin-like glycoproteins from Trypanosoma cruzi bind to CD1d but do not elicit dominant innate or adaptive immune responses via the CD1d/NKT cell pathway.
    Procópio DO; Almeida IC; Torrecilhas AC; Cardoso JE; Teyton L; Travassos LR; Bendelac A; Gazzinelli RT
    J Immunol; 2002 Oct; 169(7):3926-33. PubMed ID: 12244192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Donor bone marrow type II (non-Valpha14Jalpha18 CD1d-restricted) NKT cells suppress graft-versus-host disease by producing IFN-gamma and IL-4.
    Kim JH; Choi EY; Chung DH
    J Immunol; 2007 Nov; 179(10):6579-87. PubMed ID: 17982047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fine specificity of natural killer T cells against GD3 ganglioside and identification of GM3 as an inhibitory natural killer T-cell ligand.
    Park JE; Wu DY; Prendes M; Lu SX; Ragupathi G; Schrantz N; Chapman PB
    Immunology; 2008 Jan; 123(1):145-55. PubMed ID: 18154620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NKT cells provide help for dendritic cell-dependent priming of MHC class I-restricted CD8+ T cells in vivo.
    Stober D; Jomantaite I; Schirmbeck R; Reimann J
    J Immunol; 2003 Mar; 170(5):2540-8. PubMed ID: 12594280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD1d-restricted NKT cells: an interstrain comparison.
    Hammond KJ; Pellicci DG; Poulton LD; Naidenko OV; Scalzo AA; Baxter AG; Godfrey DI
    J Immunol; 2001 Aug; 167(3):1164-73. PubMed ID: 11466330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term survival of corneal allografts is dependent on intact CD1d-reactive NKT cells.
    Sonoda KH; Taniguchi M; Stein-Streilein J
    J Immunol; 2002 Feb; 168(4):2028-34. PubMed ID: 11823540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human invariant V alpha 24-J alpha Q TCR supports the development of CD1d-dependent NK1.1+ and NK1.1- T cells in transgenic mice.
    Capone M; Cantarella D; Schümann J; Naidenko OV; Garavaglia C; Beermann F; Kronenberg M; Dellabona P; MacDonald HR; Casorati G
    J Immunol; 2003 Mar; 170(5):2390-8. PubMed ID: 12594262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Invariant NKT cells regulate experimental autoimmune encephalomyelitis and infiltrate the central nervous system in a CD1d-independent manner.
    Mars LT; Gautron AS; Novak J; Beaudoin L; Diana J; Liblau RS; Lehuen A
    J Immunol; 2008 Aug; 181(4):2321-9. PubMed ID: 18684921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.